69.5 F
San Diego
Friday, Jun 14, 2024
-Advertisement-

Aethlon Medical Appoints Interim CEO

Aethlon Medical, a San Diego company, named Timothy Rodell as interim CEO, it was announced Dec. 13.

Rodell was previously the CEO of Colorado-based GlobeImmune, which was acquired by NantCell. He succeeds James Joyce, who will act as an Aethlon consultant during the transition.

Aethlon’s clinical-stage Hemopurifier is designed for cancer and life-threatening viral infections. The device received a Food and Drug Administration “breakthrough device” designation, which could ease the company’s regulatory path.

Rodell officially took the reins Dec. 10.

-Advertisement-

Featured Articles

Hair Today, Hair Tomorrow

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-